Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Acumen Hypotension Prediction Index – EV1000 Clinical Platform
by Edwards Lifesciences
VS
Rhythm360
by RhythmScience

AI Verdict

Tool A, Acumen HPI, specializes in predicting and managing acute hypotensive events in surgical and critical care environments, integrating with specific monitoring platforms. Conversely, Tool B, Rhythm360, is a cloud-based platform designed for comprehensive chronic cardiac care, focusing on hypertension, heart failure, and rhythm management through vendor-neutral data aggregation and workflow optimization. While both utilize AI for cardiac insights, their distinct clinical focus areas and deployment strategies make them adjacent rather than direct competitors.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose Acumen Hypotension Prediction Index if your primary concern is the real-time prediction and proactive management of acute hypotensive events in critical care or surgical settings. This tool provides clinicians with up to 15 minutes' advance notice of potential hypotension, coupled with insights into underlying hemodynamic causes, enabling timely intervention during high-acuity procedures or patient monitoring.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose Rhythm360 if…

Choose Rhythm360 if your cardiology practice requires a comprehensive, vendor-neutral platform to aggregate and analyze cardiac monitoring data from diverse devices for chronic condition management. This solution excels at reducing alert fatigue through AI-driven triage, streamlining workflows with bi-directional EHR integration and automated billing, and optimizing care for hypertension, heart failure, and rhythm disorders across a patient population.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Rhythm360
Pricing Unknown Flexible pricing model that scales with clinic size and platform usage.
Deployment On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) Cloud-based SaaS platform
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rhythm360

Rhythm360 (Tool B) offers a cloud-based SaaS platform with a HIPAA-compliant mobile application for clinicians and bi-directional EHR integration, providing broad accessibility and flexibility. Its AI-driven alert triage also directly enhances usability by reducing alert fatigue. Acumen HPI (Tool A) is integrated with a specific monitoring platform, which, while streamlined for its intended use, lacks the broader accessibility and mobile capabilities of Tool B.

Clinical Value

Rhythm360

Rhythm360 (Tool B) provides comprehensive clinical value by unifying cardiac monitoring data from various devices, offering actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue. It also includes predictive algorithms for Heart Failure Management and GDMT optimization. Acumen HPI (Tool A) offers significant value in predicting acute hypotensive events, but its scope is more focused on intraoperative and critical care settings compared to Tool B's broader chronic cardiac care management capabilities.

Pricing & Value

Rhythm360

Rhythm360 (Tool B) offers a flexible, scalable SaaS-based pricing model and explicitly includes automated CPT code documentation and billing, which provides clear financial value and transparency despite being described as 'premium pricing'. Acumen HPI (Tool A) only states 'contact-for-pricing', offering no transparency or direct value proposition regarding cost-effectiveness or revenue generation.

Enterprise Readiness

Rhythm360

Rhythm360 (Tool B) demonstrates superior enterprise readiness with its cloud-based SaaS deployment, vendor-neutral data aggregation across all major OEM devices, and extensive bi-directional EHR integration with leading systems like Epic and Cerner. Acumen HPI (Tool A) is tightly integrated with a specific vendor's platform (Edwards Lifesciences HemoSphere/EV1000), which limits its flexibility and broad adoption across diverse healthcare IT environments.

Innovation

Rhythm360

While Acumen HPI (Tool A) is innovative in its real-time, predictive machine learning for hypotension, Rhythm360 (Tool B) showcases broader innovation. Its vendor-neutral data aggregation, AI-driven alert triage, and advanced AI Data Normalization (including computer vision for PDF parsing) address more systemic interoperability and data management challenges in cardiology. The comprehensive approach to unifying disparate data sources and reducing clinician burden through AI stands out.

Support & Docs

Rhythm360

Rhythm360 (Tool B) explicitly offers optional 24/7/365 oversight by certified cardiac technicians (CCTs), indicating a robust and continuous support structure. Acumen HPI (Tool A) provides no specific information regarding its support or documentation in the provided facts, making Tool B the clear winner in this dimension based on available data.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Rhythm360
Primary Function Uses machine learning to predict hypotensive events up to 15 minutes in advance, providing clinicians with insights into hemodynamic instability and potential causes to help reduce intraoperative hypotension. AI-powered integrated platform that unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue.
Company Edwards Lifesciences RhythmScience
Target Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology
Core Predictive/Insight Focus Hypotension prediction up to 15 minutes in advance; hemodynamic instability insights (preload, afterload, contractility). Actionable insights for hypertension, heart failure (including predictive algorithms), and rhythm management.
Data Input Method Dedicated sensors (Acumen IQ cuff or sensor) Vendor-neutral data aggregation (all major OEMs: Medtronic, Boston Scientific, Abbott, Biotronik); AI Data Normalization (API, HL7, XML, PDF parsing via computer vision).
Key Differentiator HPI Parameter (0-100 likelihood score), Smart Alerts for trending hypotension, Smart Trend screen, Relationship View screen. AI-driven alert triage (reduces alert fatigue), Bi-directional EHR integration (Epic, Cerner, etc.), Automated CPT code documentation and billing.

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and Rhythm360.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI integrates directly with the Edwards Lifesciences HemoSphere Advanced Monitoring Platform, utilizing dedicated sensors for continuous hemodynamic monitoring, meaning it functions within that specific ecosystem. Rhythm360 offers bi-directional integration with major EHRs like Epic and Cerner, and aggregates data from various cardiac monitoring devices, streamlining data flow and reducing manual entry.
Acumen HPI is designed for anesthesiology, critical care, and emergency medicine, predicting intraoperative hypotension up to 15 minutes in advance and providing insights into hemodynamic instability to help clinicians manage acute events. Rhythm360 targets cardiology, providing actionable insights for hypertension, heart failure, and rhythm management by unifying cardiac monitoring data, ideal for managing chronic cardiac conditions.
Acumen HPI relies on dedicated Edwards Lifesciences sensors, such as the Acumen IQ cuff or sensor, to continuously collect hemodynamic data for its predictive algorithm, operating within a closed system tied to the Edwards monitoring platform. Rhythm360 is vendor-neutral, aggregating cardiac monitoring data from all major OEM devices using AI for data normalization across various formats like API, HL7, and PDF, allowing for a comprehensive view across diverse monitoring equipment.
Acumen HPI provides a likelihood score (0-100) for hypotension, smart alerts for trending, and a Relationship View screen offering insights into preload, afterload, and contractility, helping clinicians identify and address the root causes of instability proactively. Rhythm360 uses AI-driven alert triage to reduce alert fatigue and offers predictive algorithms for heart failure management and GDMT optimization, streamlining administrative tasks and supporting efficient patient management.
For Acumen HPI, the learning curve would primarily involve understanding the new HPI parameter, smart alerts, and the Relationship View screen within the already familiar Edwards Lifesciences HemoSphere monitoring environment, with training likely provided by Edwards Lifesciences. Rhythm360, as a cloud-based SaaS platform with a mobile application, would involve familiarization with a new interface for data aggregation and AI-driven insights, aiming to simplify daily workflows once adopted.
The description for Acumen HPI does not explicitly detail ongoing support or clinical oversight beyond its integration with the Edwards Lifesciences platform, implying standard product support. Rhythm360 offers optional 24/7/365 oversight by certified cardiac technicians (CCTs), providing an additional layer of support and monitoring for complex cardiac cases.
Acumen HPI's deployment is integrated with specific Edwards Lifesciences hardware platforms, meaning multi-site rollout would likely involve deploying the HemoSphere/EV1000 platforms and associated sensors at each location, implying a hardware-centric scaling approach. Rhythm360 is a cloud-based SaaS platform with bi-directional EHR integration and vendor-neutral data aggregation, making it highly scalable for multi-site deployments without significant on-premise hardware requirements.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform or Rhythm360

AI Tool Finder
AI-powered search. Results may not be comprehensive.